Seller record · Telehealth service

The Edit

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: The home page says the pharmacy batch-tests each medication for potency, sterility, pH and endotoxins, and no certificate of analysis or lot document is published.

At a glance

The EditTelehealth service

7/8criteria passed

Price: Semaglutide first month $200, then $259 a month; tirzepatide first month $300, then $349
Sells: compounded tirzepatide, compounded semaglutide, NAD+ injection, and 6 more
FDA letters: None on file

Visit The Edit See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A Texas telehealth service selling compounded semaglutide and tirzepatide with first-month pricing, NAD+, sermorelin, glutathione and GHK-Cu, plus women's hormone therapy. Care comes from a named medical practice, and every prescription is filled by one named Florida pharmacy.

Operating entity The Edit Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	The Edit's help center page; The Edit's products page; The Edit's terms
S2	Prescription gating	PASS	The Edit's sema intake page on its sign-up site; The Edit's help center page
S3	Pharmacy identification	PASS	The Edit's help center page; The Edit's terms
S4	Compounding disclosure	PASS	The Edit's products page; The Edit's weight loss page; The Edit's semaglutide page
S5	Analytical documentation	FAIL	The Edit's website; The Edit's semaglutide page
S6	Business address	PASS	The Edit's website; The Edit's terms; The Edit's refund page
S7	Price disclosure	PASS	The Edit's semaglutide page; The Edit's tirzepatide page; The Edit's products page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider in the patient's state reviews each health history and decides whether treatment is appropriate, and clinical care is provided by the affiliated medical practice Arora Health & Aesthetics, LLC.Source: The Edit's help center page; The Edit's products page; The Edit's terms.

S2PASSThe start button opens a visit whose first screen asks for an email address to set up the patient portal before the health questions, and the pages say no charge is made if a provider does not approve.Source: The Edit's sema intake page on its sign-up site; The Edit's help center page.

S3PASSThe help center names The Pharmacy Hub as the pharmacy that fills every prescription, and the terms give its street address in Miami, FL.Source: The Edit's help center page; The Edit's terms.

S4PASSThe treatments page and the weight loss answers state that compounded medications are not FDA-approved, and each GLP-1 product page labels the medication compounded.Source: The Edit's products page; The Edit's weight loss page; The Edit's semaglutide page.

S5FAILThe home page says the pharmacy batch-tests each medication for potency, sterility, pH and endotoxins, and no certificate of analysis or lot document is published.Source: The Edit's website; The Edit's semaglutide page.

S6PASSThe Edit Health LLC at 5900 Balcones Drive STE 100, Austin, TX 78731, printed in the footer of every page and in the terms and the refund policy.Source: The Edit's website; The Edit's terms; The Edit's refund page.

S7PASSCompounded semaglutide at $259 a month, with a first month at $200 marked as limited-time pricing, or $192 a month on a 3-month plan billed $575 and $178 a month on a 6-month plan billed $1,065. Compounded tirzepatide at $349 a month, with a first month at $300, or $285 a month billed $855 for 3 months and $263 a month billed $1,575 for 6 months, the same price at every dose. The NAD+ injection at $249 a month, sermorelin at $169, glutathione at $199 and GHK-Cu cream from $129.Source: The Edit's semaglutide page; The Edit's tirzepatide page; The Edit's products page.

S8PASSNo FDA warning letter names The Edit or The Edit Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded tirzepatide, compounded semaglutide, NAD+ injection, sermorelin, glutathione injection, GHK-Cu topical cream, estradiol, progesterone, Biest 50:50.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells GHK-Cu

Visit The Edit

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.